Matters of legal in nature including licensing, intellectual property, and lawsuits.
Approval allows use of therascreen® EGFR RGQ PCR Kit as a companion diagnostic for Pfizer’s VIZIMPRO® (dacomitinib) in patients with non-small cell lung cancer Germantown, Maryland, and Hilden, Germany, September 28, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has approved a PMA Supplement... Read more
SANTA CLARA, Calif., September 18, 2018 Agilent Technologies Inc. (NYSE: A) filed a new complaint against Twist Bioscience Corp. (“Twist”) and Emily Leproust. The proposed Second Amended Complaint adds two additional defendants (Twist employee Siyuan Chen and former Twist employee Solange Glaize) and adds new facts that were recently discovered regarding the defendants’ wide-ranging theft... Read more
Download PDF SAN FRANCISCO, Calif. – September 18, 2018 — Twist Bioscience issued the following statement: Agilent’s wholesale shift in its allegations, two and a half years into its suit, reveals only the weakness of its claims. Agilent’s most recent allegations are gamesmanship, not substance. They omit that more than four months before it sought to change its... Read more
SANTA CRUZ, Calif., Sept. 18, 2018 /PRNewswire/ — SomaGenics, a biotechnology company focused on developing lowest bias sequencing and highest specificity RT-qPCR technologies for small RNAs, announced today the issue of US Patent 10,041,107, a continuation of SomaGenics’ patent family entitled “Methods and Compositions for Detection of small RNAs.” The new patent broads protection for SomaGenics’ innovative,... Read more
New license agreements for CRISPR technology from Broad Institute and ERS Genomics extend industry-leading genome editing capabilities CARLSBAD, Calif., Sept. 18, 2018 /PRNewswire/ — Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing... Read more
Secures and Consolidates Unrestricted Rights for Simoa Technology in Diagnostics Market LEXINGTON, Mass.–(BUSINESS WIRE)–Sep. 12, 2018– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the consolidation of its licensing position and reestablishment of control of its intellectual property in the in vitro diagnostics (IVD) field. The termination... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Sep. 5, 2018– Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its President and Chief Executive Officer, Patrick Decker, and Sr. Director of Investor Relations, Matthew Latino will participate in group discussions at the Morgan Stanley 6th Annual Laguna... Read more
Download as PDF August 30, 2018 Invention Opens Path for Integration of Automated ”Hands-Free” Sample Prep Workflows Utilizing Company’s Patented High-Pressure Platform Technologies SOUTH EASTON, MA / ACCESSWIRE / August 30, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (”PBI” or the ”Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its MiSeq™Dx Sequencing System received the approval certificate from the China National Drug Administration (CNDA). This is Illumina’s first CNDA-cleared, next-generation sequencing (NGS) system in China. In accordance with the clearance, Illumina can now market and sell the MiSeqDx Sequencing System to hospitals and other medical institutions... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Aug. 27, 2018– Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its Senior Vice President and President, Americas Commercial Team and Applied Water SystemsKen Napolitano and Sr. Director of Investor Relations Matt Latino will participate in the Seaport Global... Read more